Sign in to view content

Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes

Keyvan Koushan, MD, FRCSC

Audio
Published 2019

Related

Elamipretide, a Mitochondria-Targeted Drug for the Treatment of Vision Loss
Scott W. Cousins, MD
Updates from the Field
2019
Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD
Robert L. Avery, MD
Updates from the Field
2021
Autologous Retinal Transplant for Macular Holes: Initial Experience
Tamer H. Mahmoud, MD, PhD
Updates from the Field
2017

Category: Age-Related Macular Degeneration

See more